Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain
Status:
RECRUITING
Trial end date:
2028-06-01
Target enrollment:
Participant gender:
Summary
This protocol aims to test whether an infusion of allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs) can reduce pain associated with chronic pancreatitis (CP) and explore potential mechanisms of MSC action.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Medical University of South Carolina
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)